A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES

A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES

Myeloperoxidase is a key factor promoting development of halogenative/oxidative stress under inflammatory conditions. Previously, we have discovered complexes including myeloperoxidase and its physiological inhibitor, ceruloplasmin in blood plasma of patients with inflammatory diseases of different...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Sokolov, V. A. Kostevich, N. V. Gorbunov, D. V. Grigorieva, I. V. Gorudko, V. B. Vasilyev, O. M. Panasenko
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2018-11-01
Series:	Медицинская иммунология
Subjects:	myeloperoxidase halogenative stress ceruloplasmin peroxidase activity cardiovascular diseases biomarker
Online Access:	https://www.mimmun.ru/mimmun/article/view/1638
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a Microfluidic Paper-Based Analytical Device for Myeloperoxidase Detection in Periodontitis
by: Juliane Caroline Leão, et al.
Published: (2025-07-01)

Myeloperoxidase enzyme-catalyzed breakdown of zero-dimension carbon quantum dots
by: Pooja Singh, et al.
Published: (2024-11-01)

Wilson's disease patients with normal ceruloplasmin levels
by: Aysel Yüce, et al.
Published: (1999-01-01)

Evaluation of salivary ceruloplasmin for the diagnosis of Wilson’s disease
by: Nian Zhang, et al.
Published: (2025-03-01)

The influence of iron and germanium nanocompounds on the content of ceruloplasmin in the blood of sows and piglets obtained from them
by: O. O. Kovalchuk, et al.
Published: (2023-12-01)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)

The Utility of Myeloperoxidase Immunostaining to Characterize Immune Deposits in Patients With Crescentic Glomerulonephritis
by: Rachelle Gietzen, et al.
Published: (2025-05-01)

Ceruloplasmin and complement C3 are markers of diminished ovarian reserve in premenopausal women
by: M. D. Salimova, et al.
Published: (2023-04-01)

Alteration of ceruloplasmin in patients with malaria: a systematic review and meta-analysis of observational studies
by: Kwuntida Uthaisar Kotepui, et al.
Published: (2024-11-01)

Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
by: Alan Zanardi, et al.
Published: (2017-11-01)

Absence of astrocytic ceruloplasmin reverses the senescence process with aging of learning and memory abilities
by: Zhong-Da Li, et al.
Published: (2025-05-01)

Serum ceruloplasmin ,copper and iron levels as a risk factors for coronary heart diseases(CHD)
by: Baghdad Science Journal
Published: (2010-03-01)

Ceruloplasmin as a Vital Tool for Grading of Preeclampsia: A Case-Control Study in Central India
by: Kapil Raghuwanshi, et al.
Published: (2025-05-01)

Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer’s disease
by: Astrid Mayleth Rivera Antonio, et al.
Published: (2025-12-01)

Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population dataResearch in context
by: Nicole Ziliotto, et al.
Published: (2025-03-01)

Relationship between reduced serum ceruloplasmin levels and executive dysfunction in hospitalized schizophrenia patients
by: Dan Kuang, et al.
Published: (2025-08-01)

Challenges in myeloperoxidase quantification: the inadequacies of current colorimetric approaches
by: Ian Jhemes Oliveira Sousa, et al.
Published: (2025-04-01)

Estimation of myeloperoxidase levels in smokers, pan chewers, and normal individuals using enzyme-linked immunosorbent assay: An observational study
by: Meyyappan Arunachalam, et al.
Published: (2024-01-01)

Ceruloplasmin and some biochemical parameters as a marker for acute myeloid leukemic patients
by: Ayinda Mariwan Mohsen, et al.
Published: (2023-08-01)

Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition
by: Britney Niemann, et al.
Published: (2025-08-01)

Management of myeloperoxidase activity of leukocytes in those suffering from community acquired pneumonia with the help of low-intesive lazer radiation of blood
by: N. M. Burduli, et al.
Published: (2016-04-01)

Role of myeloperoxidase in atrial fibrillation and ischemic heart disease
by: G. F. Bunenkova, et al.
Published: (2023-01-01)

Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
by: Kenta Tominaga, et al.
Published: (2024-07-01)

Chlorine Inactivation of Elizabethkingia spp. in Water
by: David A. Holcomb, et al.
Published: (2024-10-01)

Interleukin-17 and myeloperoxidase levels in patients with non-alcoholic fatty liver disease and effect of disease severity on blood counts and liver enzymes
by: Mamoona Nazir, et al.
Published: (2025-03-01)

The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD
by: E. Jiang, et al.
Published: (2025-04-01)

CLINICAL-PATHOGENIC IMPORTANCE OF CORRELATION BETWEEN HISTOCHEMICAL INDICES OF BLOOD SYSTEM AND RHEUMATOID FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A B Zborovsky, et al.
Published: (2001-04-01)

Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01)

Integrated analysis of myeloperoxidase in gastric health and cancer: associations with pepsinogen levels, immune regulation, and prognosis in a large healthy population-based and TCGA cohorts
by: Junteng Zhou, et al.
Published: (2025-06-01)

THE ANTIOXIDATIVE DEFENCE IN WOMEN WITH EXTERNAL ENDOMETRIOSIS
by: L. V. Adamyan, et al.
Published: (2016-06-01)

U-shaped association between myeloperoxidase levels and anxiety risk: a cross-sectional study in a Chinese population
by: Junteng Zhou, et al.
Published: (2025-05-01)

Neutrophil myeloperoxidase index in pediatric acute appendicitis
by: Stanković Nikola, et al.
Published: (2019-01-01)

Role of NT-proBNP and Myeloperoxidase as Predictors of Abnormal Stress Test Results and Revascularization in Intermediate-Risk NSTE-ACS: A Prospective Study
by: Enrique Soltero-Mariscal, et al.
Published: (2025-02-01)

Wilson’s disease in a child: a difficult path to diagnosis (clinical case)
by: O.M. Вabadzhanian, et al.
Published: (2025-05-01)

Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population
by: Olga A. Iakoubova, et al.
Published: (2025-04-01)

Predictive value of serum myeloperoxidase (MPO) concentration combined with triglyceride-glucose index (TyG) for major adverse cardiaovascular events (MACE) in patients with coronary heart disease
by: Adila Wulamu, et al.
Published: (2025-12-01)

THE ROLE OF HALOGENS AND SULFUR IN APATITE FOR EVALUATION OF Cu-Ni, Fe-Ti AND Au ORES IN LATE PALAEOZOIC GABBROIDS OF THE WEST MAGNITOGORSK ZONE (SOUTH URALS)
by: V.V. Holodnov, et al.
Published: (2015-09-01)

Clinical and immunological variants of ANCA-associated systemic vasculitis: a look at the pulmonary fibrosis in microscopic polyangiitis with anti-myeloperoxidase antibodies and rheumatoid factor. Literature review and own observation
by: T. V. Beketova, et al.
Published: (2023-03-01)

Effect of Pregnancy on Selenium, Cupper ,Zinc and Others Biochemical Feacture
by: Baghdad Science Journal
Published: (2013-12-01)

Biochemical predictors of chronic kidney disease in children recovering from acute kidney injury
by: O. V. Lavrenchuk, et al.
Published: (2021-02-01)